Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen to all the different tissues in your body and removing carbon dioxide to ...
That’s the conclusion of hiring managers at four of the state’s leading life sciences companies who spoke at a recent career ...
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...
If walking is becoming difficult and physio isn’t working, cutting-edge treatments could be the next step. But which ones are ...
New blinded preliminary BRTX-100 data described this past Saturday at prestigious “2025 Winners in Industry Innovations in MSK Health” ...
PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points PHC has ...
The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback